Region Gaevleborg

Clinical trials at this hospital-based site focus on neoplasms, with research centered on improving care for people with cutaneous malignant melanoma and small cell lung cancer. The studies are designed to evaluate new treatment approaches and better define how long immunotherapy should be used after surgery or alongside other cancer treatments.

• Testing whether shorter immunotherapy can provide similar benefit after surgery for high-risk melanoma
• Comparing combination treatment strategies for advanced small cell lung cancer against standard chemotherapy
• Assessing treatment effectiveness and survival outcomes in patients with advanced cancer

This work reflects a focused oncology program in Gavle that aims to improve survival and refine treatment choices for patients with difficult-to-treat cancers.

At Lungenheten, the clinical trial portfolio is concentrated in oncology, with particular attention to skin cancer and lung cancer. The research is exploring whether newer treatment combinations can improve outcomes, while also helping clinicians understand the most effective duration and use of cancer therapy.

• Cutaneous malignant melanoma studies examining post-surgery immunotherapy
• Small cell lung cancer research evaluating a new treatment combination for advanced disease
• Clinical efforts aimed at improving overall survival and treatment effectiveness

With a small but targeted set of trials, the site contributes to practical advances in cancer care for patients in the Region Gaevleborg area.